WOLVERINE ASSET MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$4,523,000
+11.6%
448,272
+10.8%
0.05%
+19.5%
Q2 2022$4,053,000
+162.2%
404,576
+161.7%
0.04%
+173.3%
Q1 2022$1,546,000
-3.0%
154,566
-3.9%
0.02%0.0%
Q4 2021$1,593,000160,7930.02%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders